Dublin, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The "Diagnostic Specialty Antibodies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)" report has been added to ResearchAndMarkets.com's offering.
The global Diagnostic Specialty Antibodies Market is projected to grow at a compound annual growth rate (CAGR) of 5.95% during the forecast period.
The market has experienced significant impact due to the COVID-19 pandemic, witnessing a surge in the usage of diagnostic antibodies for the detection of COVID-19 during the initial phase. However, with the adoption of other diagnostic methods like PCR and antigen tests, the market is expected to return to pre-pandemic levels in the forecast period.
The rise in DNA-based technologies and diagnostics, coupled with the increasing number of patients undergoing HIV diagnosis, is expected to fuel market growth. Moreover, the prevalence of infectious diseases, influenza, and cancer is driving the demand for diagnostic antibodies.
Monoclonal antibodies are expected to witness significant growth during the forecast period, playing a vital role in the diagnosis of infectious and chronic diseases, particularly cancer. These antibodies are incorporated into diagnostic techniques such as western immunoblotting, ELISA, immunofluorescence tests, and immunohistochemistry, providing accurate and rapid diagnosis for various diseases.
North America is projected to have substantial market growth, driven by the region's adaptation of antibody diagnostics, well-established healthcare infrastructure, and increased funding for cancer research. The high prevalence of cancer in the United States is a major factor contributing to the demand for diagnostic specialty antibodies in the oncology field.
"We are witnessing significant advancements in DNA-based technologies and diagnostics, along with a growing demand for accurate and rapid diagnosis of various diseases, which is positively impacting the diagnostic specialty antibodies market," said a spokesperson from the research team.
The market's competitive landscape includes prominent international and local companies, such as F. Hoffmann-La Roche AG, Abcam plc, Bio-Rad Laboratories, Inc., Abbott Laboratories, and Thermo Fisher Scientific Inc., among others.
A selection of companies mentioned in this report includes
- F. Hoffmann-La Roche AG
- Abcam plc
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Creative Diagnostics
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- Merck KGaA
- Sartorius AG
For more information about this report visit https://www.researchandmarkets.com/r/55h54i
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
